Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VTYX | Common Stock | Conversion of derivative security | +785K | 785K | Oct 25, 2021 | See Footnotes | F1, F2, F3 | |||
transaction | VTYX | Common Stock | Purchase | $10M | +625K | +79.59% | $16.00 | 1.41M | Oct 25, 2021 | See Footnotes | F2, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VTYX | Series A Convertible Preferred Stock | Conversion of derivative security | -548K | -100% | 0 | Oct 25, 2021 | Common Stock | 548K | See Footnotes | F1, F2, F5 | |||
transaction | VTYX | Series B Convertible Preferred Stock | Conversion of derivative security | -237K | -100% | 0 | Oct 25, 2021 | Common Stock | 237K | See Footnotes | F1, F2, F6 |
Cormorant Asset Management, LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Shares of Series A and Series B Convertible Preferred Stock were convertible at any time at the holder's election, without payment of additional consideration. Such shares had no expiration date but converted into Common Stock automatically upon the closing of the Issuer's initial public offering. |
F2 | Shares reported herein are held by Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), and a managed account (the "Account"). Cormorant Asset Management, LP ("Cormorant") serves as the investment manager of the Master Fund, Fund III, and the Account. Bihua Chen serves as manager of the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose. |
F3 | Represents (i) 169,075 shares held by the Master Fund, (ii) 611,568 shares held by Fund III, and (iii) 4,660 shares held by the Account. |
F4 | Shares reported herein as purchased on October 25, 2021 represent 625,000 shares purchased by the Master Fund. |
F5 | The Series A Convertible Preferred Stock represented, on an as-converted basis, (i) 118,046 shares held by the Master Fund, (ii) 425,582 shares held by Fund III, and (iii) 4,660 shares held by the Account. |
F6 | The Series B Convertible Preferred Stock represented, on an as-converted basis, (i) 51,029 shares held by the Master Fund and (ii) 185,986 shares held by Fund III. |